Pancreatic Cancer Research

ResearcherSheng Jing HospitalActive in the last 2 years

Zhen Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5338-7219; OpenAlex author ID A5100411997. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 4

  1. The DDX6/KIFC1 signaling axis, as regulated by YY1, contributes to the malignant behavior of pancreatic cancer. First author DOI 10.1096/fj.202400166r↗
  2. Prognosis and survival analysis of patients with pancreatic cancer: retrospective experience of a single institution. Last author DOI 10.1186/s12957-021-02478-x↗
  3. Analysis of dysregulation of immune system in pancreatic cancer based on gene expression profile. Last author DOI 10.1007/s11033-014-3307-2↗
  4. Identification of genes and candidate agents associated with pancreatic cancer. First author DOI 10.1007/s13277-013-1009-3↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Baosheng Wang · 1 shared paper, 2024 · strength 0.28
  2. Xiangpeng Meng · 1 shared paper, 2024 · strength 0.28
  3. Xin Deng · 1 shared paper, 2024 · strength 0.28
  4. Xun Liu · 1 shared paper, 2022 · strength 0.19
  5. Qi Li · 1 shared paper, 2022 · strength 0.19
  6. Baosheng Wang · 2 shared papers, 2014 · strength 0.13
  7. Shaolong Sun · 2 shared papers, 2014 · strength 0.13
  8. Yi Zhao · 1 shared paper, 2014 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.